EQRX Inc.  logo

EQRX

EQRX Inc.

$3.79

Earnings Summary

Revenue
$0Mn
Net Profits
$20.73Mn
Net Profit Margins
+Inf%

Highlights

Revenue:

EQRX Inc. ’s revenue jumped NaN% since last year same period to $0Mn in the Q1 2022. On a quarterly growth basis, EQRX Inc. has generated NaN% jump in its revenue since last 3-months.

Net Profits:

EQRX Inc. ’s net profit jumped 177.29% since last year same period to $20.73Mn in the Q1 2022. On a quarterly growth basis, EQRX Inc. has generated 120.72% jump in its net profits since last 3-months.

Net Profit Margins:

EQRX Inc. ’s net profit margin jumped NaN% since last year same period to +Inf% in the Q1 2022. On a quarterly growth basis, EQRX Inc. has generated NaN% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the EQRX Inc. post its latest quarter earnings

EPS Estimate Current Quarter
-0.22
EPS Estimate Current Year
-0.22

Highlights

EPS Estimate Current Quarter:

EQRX Inc. ’s earning per share (EPS) estimates for the current quarter stand at -0.22 - a -8.03% fall from last quarter’s estimates.

EPS Estimate Current Year:

EQRX Inc. ’s earning per share (EPS) estimates for the current year stand at -0.22.

Key Ratios

Key ratios of the EQRX Inc. post its Q4 2022 earnings

Earning Per Share (EPS)
0

Highlights

Earning Per Share (EPS):

EQRX Inc. ’s earning per share (EPS) fell -100% since last year same period to 0 in the Q4 2022. This indicates that the EQRX Inc. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2023-03-22
-0.22
0
100%
2022-11-10
-0.21
0
100%
2022-08-11
-0.2
-0.17
13.57%
2022-05-13
-0.25
0.04
116.33%

Company Information

EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States.

Organisation
EQRX Inc.
Headquarters
50 Hampshire Street, Cambridge, MA, United States, 02139
Employees
240
Industry
Healthcare
CEO
Melanie I. Nallicheri

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*